RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Method for Treating or Retarding the Development of Blindness: Gene Therapy Clinical Trial
Method for Treating or Retarding the Development of Blindness: Gene Therapy Clinical Trial More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Apr 2010 - 510 pages - $2,695
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
Dec 2009 - 90 pages - $3,800
Gene Signal International SA. – Product Pipeline Review – Q1 2011
Mar 2011 - 34 pages - $500
Personalized Medicine Partnering Terms and Agreements
Apr 2011 - 951 pages - $4,995
Deals and alliances in sensory and dental diseases
Jun 2006 - 422 pages - $2,495
Gene Express, Inc. - Product Pipeline Analysis
Mar 2011 - 24 pages - $750
Coldwell Banker Gene Armstrong, Inc. - Company Capsule
Nov 2011 - 6 pages - $75
TransMedics, Inc. - Product Pipeline Analysis
Mar 2011 - 21 pages - $750
Avir Green Hills Biotechnology AG – Product Pipeline Review – Q1 2011
Mar 2011 - 26 pages - $500
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Oct 2010 - 598 pages - $2,695
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Gene therapy del
Therapeutic target
Sensory organ del
Development phase
Phase I del

Browse By

Therapeutic target
Auditory
Opthalmic

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us